Lv1
50 积分 2021-05-13 加入
EP.12E.05 Exploring Clinical Characteristics and Treatment Outcomes of Squamous Cell Lung Cancers Harboring EGFR and ALK Mutations: A Case Series
1个月前
已完结
Small Cell Lung Cancer with de novo BRAF V600E mutation and durable response to targeted therapy: a case report
1个月前
已完结
Unfavorable response to capmatinib for MET exon14 skipping after first-line osimertinib in a patient with EGFR-mutated lung adenocarcinoma: A case report and literature review
1个月前
已完结
EP.12A.39 MET Point Mutations as the Mechanism of Resistance to EGFR-TKI Therapy: A Case Report of MET H1094Y-Mediated Resistance to Osimertinib Overcome by Capmatinib and a Systematic Review
1个月前
已完结
Tepotinib plus an EGFR tyrosine kinase inhibitor in patients with EGFR-mutant MET-altered NSCLC: A case series
1个月前
已完结
Nonbacterial thrombotic endocarditis (NBTE) treated with crizotinib in lung adenocarcinoma harboring ROS-1 rearrangement: two case report and review of literature
1个月前
已完结
Diabetic Ketoacidosis During Lorlatinib Treatment: Case Report
1个月前
已关闭
Complex Dyslipidemia Induced by Lorlatinib Therapy: A Case Study
1个月前
已完结
MSR156 Quantifying Bias in Matching Adjusted Indirect Comparisons (MAIC): A Case Study With Entrectinib in Metastatic ROS-1 Positive Non-Small Cell Lung Cancer (NSCLC)
1个月前
已完结
Nonbacterial thrombotic endocarditis (NBTE) treated with crizotinib in lung adenocarcinoma harboring ROS-1 rearrangement: two case report and review of literature
1个月前
已完结
皖公网安备34019202002308
